{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:08:55Z","timestamp":1793614135722,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.aohep.2023.101281","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T10:39:19Z","timestamp":1703155159000},"page":"101281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["From NAFLD to MASLD: When metabolic comorbidity matters"],"prefix":"10.1016","volume":"29","author":[{"given":"Shan","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxia","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8893-653X","authenticated-orcid":false,"given":"Hongshan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2023.101281_bib0001","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.aohep.2023.101281_bib0002","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221145549","article-title":"MAFLD: a multisystem disease","volume":"14","author":"Pipitone","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.aohep.2023.101281_bib0003","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.aohep.2023.101281_bib0004","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2023.101281_bib0005","article-title":"Metabolic dysfunction: the silenced connection with fatty liver disease [published online ahead of print, 2023 Jul 17]","volume":"28","author":"Ram\u00edrez-Mej\u00eda","year":"2023","journal-title":"Ann Hepatol"},{"issue":"10290","key":"10.1016\/j.aohep.2023.101281_bib0006","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.aohep.2023.101281_bib0007","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2023.101281_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154433","article-title":"MAFLD and risk of CKD","volume":"115","author":"Sun","year":"2021","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.aohep.2023.101281_bib0009","doi-asserted-by":"crossref","first-page":"329","DOI":"10.14218\/JCTH.2021.00178","article-title":"Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver","volume":"10","author":"Kaya","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"23","key":"10.1016\/j.aohep.2023.101281_bib0010","first-page":"00418","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"S0168-8278","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2023.101281_bib0011","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.cgh.2020.10.046","article-title":"Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease","volume":"19","author":"Wong","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2023.101281_bib0012","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.aohep.2023.101281_bib0013","first-page":"00928","article-title":"Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: a nationwide study with 5.7 million adults in China","volume":"S0016-5085","author":"Man","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.aohep.2023.101281_bib0014","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.aohep.2023.101281_bib0015","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.aohep.2023.101281_bib0016","article-title":"Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma","volume":"5","author":"Song","year":"2023","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.aohep.2023.101281_bib0017","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101281_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155664","article-title":"From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need","volume":"147","author":"Kokkorakis","year":"2023","journal-title":"Metabolism"},{"issue":"23","key":"10.1016\/j.aohep.2023.101281_bib0019","first-page":"05000","article-title":"Can we use old NAFLD data under the new MASLD definition? [published online ahead of print, 2023 Aug 2]","volume":"S0168-8278","author":"Song","year":"2023","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2023.101281_bib0020","first-page":"594","article-title":"NAFLD early in life associated with increased long-term mortality","volume":"18","author":"Ray","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2023.101281_bib0021","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101281_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101274","article-title":"NAFLD - a rising metabolic disease","volume":"50","author":"Zeigerer","year":"2021","journal-title":"Mol Metab"},{"issue":"3","key":"10.1016\/j.aohep.2023.101281_bib0023","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/ijms19030911","article-title":"Genetic and epigenetic regulation in nonalcoholic fatty liver disease (NAFLD)","volume":"19","author":"Del Campo","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.aohep.2023.101281_bib0024","first-page":"05080","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical [published online ahead of print, 2023 Sep 9]","volume":"S0168-8278","author":"Hagstr\u00f6m","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101281_bib0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.aohep.2023.101281_bib0026","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.cgh.2022.06.029","article-title":"Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD - a systematic review and meta-analysis","volume":"21","author":"Tang","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2023.101281_bib0027","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"323","key":"10.1016\/j.aohep.2023.101281_bib0028","doi-asserted-by":"crossref","first-page":"323rv1","DOI":"10.1126\/scitranslmed.aad8390","article-title":"The intersection of nonalcoholic fatty liver disease and obesity","volume":"8","author":"Woo Baidal","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.aohep.2023.101281_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113331","article-title":"Recent advances in lean NAFLD","volume":"153","author":"Xu","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"9491","key":"10.1016\/j.aohep.2023.101281_bib0030","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"IDF epidemiology task force consensus group. The metabolic syndrome\u2013a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.aohep.2023.101281_bib0031","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","article-title":"Epidemiology and determinants of obesity in China [published correction appears in Lancet Diabetes Endocrinol. 2021 Jul;9(7):e2]","volume":"9","author":"Pan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.aohep.2023.101281_bib0032","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/17474124.2018.1460202","article-title":"The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis","volume":"12","author":"Lu","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"42","key":"10.1016\/j.aohep.2023.101281_bib0033","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.3748\/wjg.v26.i42.6514","article-title":"Nonalcoholic fatty liver disease in lean subjects: prognosis, outcomes and management","volume":"26","author":"Chrysavgis","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.aohep.2023.101281_bib0034","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s13679-022-00473-1","article-title":"Hepatocyte mitochondrial dynamics and bioenergetics in obesity-related non-alcoholic fatty liver disease","volume":"11","author":"Legaki","year":"2022","journal-title":"Curr Obes Rep"},{"issue":"7","key":"10.1016\/j.aohep.2023.101281_bib0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/0003319719848204","article-title":"Perirenal adiposity and other excessive intra- and peri-organ fat depots: what is the connection?","volume":"70","author":"Katsiki","year":"2019","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.aohep.2023.101281_bib0036","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/17474124.2020.1820321","article-title":"Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver","volume":"15","author":"Ramos","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2023.101281_bib0037","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3350\/cmh.2022.0237","article-title":"Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis","volume":"29","author":"Lee","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2023.101281_bib0038","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.aohep.2023.101281_bib0039","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.aohep.2023.101281_bib0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep4.1285","article-title":"Prevalence of nonalcoholic fatty liver disease in the female population","volume":"3","author":"Arshad","year":"2018","journal-title":"Hepatol Commun"},{"issue":"11","key":"10.1016\/j.aohep.2023.101281_bib0041","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/hep4.1419","article-title":"Mortality related to nonalcoholic fatty liver disease is increasing in the United States","volume":"3","author":"Paik","year":"2019","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.aohep.2023.101281_bib0042","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0028-1091978","article-title":"The epidemiology of nonalcoholic fatty liver disease: a global perspective","volume":"28","author":"Lazo","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.aohep.2023.101281_bib0043","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101281_bib0044","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/131528","article-title":"The influence of metabolic factors for nonalcoholic Fatty liver disease in women","volume":"2015","author":"Chung","year":"2015","journal-title":"Biomed Res Int"},{"issue":"12","key":"10.1016\/j.aohep.2023.101281_bib0045","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.3390\/nu13124556","article-title":"Energy metabolism changes and dysregulated lipid metabolism in postmenopausal women","volume":"13","author":"Ko","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.aohep.2023.101281_bib0046","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2017.03.008","article-title":"Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature","volume":"120","author":"Pucci","year":"2017","journal-title":"Pharmacol Res"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123003848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123003848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T04:53:02Z","timestamp":1713588782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268123003848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1665268123003848"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101281","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From NAFLD to MASLD: When metabolic comorbidity matters","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101281"}}